Turn Bio Acquires Vesigen’s Microvesicle Delivery System for Epigenetic Therapies

Turn Biotechnologies, a biotechnology company based in Mountain View, California, announced on March 26, 2025, the acquisition of ARMMs (ARRDC1-Mediated …

Continue ›››

seca Presents Real-Time Body Composition Tracker for Personalized Care

seca, a global Hamburg-based medical measurement company founded in 1840, has introduced a new software platform called "Treatment Tracker," which …

Continue ›››

Oxford Nanoimaging Launches ML-Driven Platform for Lipid Nanoparticle Characterization

Oxford Nanoimaging (ONI), founded in 2016 as a spin-out from the University of Oxford and headquartered in Oxford, UK, and …

Continue ›››

A Call to Improve the UK Life Sciences Sector, Home to Over 6,800 Companies

In October 2024, the UK Government released an Industrial Strategy green paper outlining a 10-year plan for the sustainable economic …

Continue ›››

Spatial Biology Company Alpenglow Biosciences Unveils 3D Imaging Interface for Light-Sheet Microscopy

Alpenglow Biosciences, a spatial biology company focused on 3D imaging, presented a new imaging interface, titled "LUMI", for light-sheet microscopy …

Continue ›››

Report: Nearly 80% of Life Sciences Leaders Considering Virtual Models for Observational Research

A new industry report from PicnicHealth reveals that nearly 80% of life sciences leaders are open to using virtual models …

Continue ›››

YC Startup ReactWise Raises $3.4M in Pre-Seed to Develop AI-Driven Robotic Labs for Drug Manufacturing

ReactWise, a UK-based startup developing AI-driven robotic laboratories for pharmaceutical and chemical manufacturing, has raised $3.4 million in pre-seed funding. …

Continue ›››

Roivant Spinout Debuts AI Model to Combine Biomolecule Structure Prediction and Generation

VantAI, a NY-based spinout of Roivant founded in 2019, has introduced Neo-1, an artificial intelligence model that integrates atomic-level biomolecule …

Continue ›››

23andMe Files for Bankruptcy

23andMe, the consumer genetics company, has filed for Chapter 11 bankruptcy protection and initiated a sale process. The filing comes …

Continue ›››

Lilly-Backed Ampersand Raises $65M for Preclinical Immunology and Computational Drug Discovery

Ampersand Biomedicines has raised $65 million in a Series B funding round, with participation from Eli Lilly and Company and …

Continue ›››

Microsoft and Inait to Develop Brain-Inspired AI for Finance and Robotics

Microsoft and Swiss startup Inait have announced a partnership to develop AI models inspired by mammalian brain function. Microsoft plans …

Continue ›››

Proscia Raises $50M to Expand AI Pathology Platform and Precision Medicine Tools

Proscia, a developer of AI-based pathology software, has raised $50 million in funding, bringing its total capital raised to $130 …

Continue ›››